Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.4.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.41ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.41NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CA.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CA.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
BE.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BH.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BH.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BL.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BL.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BS.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BS.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BS.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BS.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.13.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used